Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go:
20
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Monva is a financial technology platform that uses Artificial Intelligence (AI) to revolutionise the price comparison experience and personalise customer offers. It argues that only 38% of people in the UK trust Price Comparison Websites (PCWs) with the majority being wary of such entities. Monva aims to change that. Its AI Chatbot ‘Mo’ helps customers save time by suggesting search queries, highlighting key information to assist in making switching decisions, and providing alerts to new automated offers. The company has raised £625,000 in 2020 from DBW, Angels and crowdfunding sites. It was also overfunded by >200%. It aims to become a contender in the price comparison market valued at £2.8 billion. It will use the investment to continue building its smart comparison technology, secure commercial partnerships, and grow its marketing activity.
days to go:
Expired
investment:
£451,905
Genuine Impact is the next generation financial terminal made exclusively to empower DIY investors by providing experts with automation tools, portfolio enhancer, unbiased data and insights. Genuine Impact is more cost-effective in comparison with traditional financial terminals, and it makes financial research effortless and efficient. Currently, the company's beta app has 500+ users from more than 27 countries. With the proceeds, the fund raised will be used for new product development, enhancement of existing product and for marketing and branding.
days to go:
Expired
investment:
£500,920
Cuckooz Nest is London’s pay-as-you-go nursery with an integrated workspace for the modern working parent. With the ability to support both individuals and bigger businesses, it bridges the gap between work and life by providing an accessible, flexible, affordable and scalable childcare. It has already helped over 100 families to attain a greater work-life balance. Cuckooz Nest has also been shortlisted for many awards such as Best Workspace, Nursery Innovation Award, and The People’s Choice Award. With the same purpose to provide creative childcare solutions, this company has partnered with Manny & Me, a London-based agency, to ensure the delivery of the highest quality of staff and educational programming.Cuckooz Nest, with the proceeds, is planning to set up a much larger site to help a substantial number of men and women manage their work and family.
days to go:
Expired
investment:
£131,650
Riversimple is a car manufacturer and service provider that is spearheading ‘next-generation’ Hydrogen electric vehicles. It sells mobility as a service and retains ownership of its cars. Their pricing structure allows customers to pay a single monthly fee that covers the vehicle, fuel, maintenance, and insurance costs. It's proprietary offering, Rasa, is a two-seat local commuter vehicle that can achieve a 250mpg equivalent fuel figure with a 300-mile range from a 3-minute fill. The company has recently been awarded two new grants from The Office for Low Emission Vehicles (OLEV) for £1.25 million to support the build of its first low volume production run, and another from InnovateUK worth £0.5 million to support the deployment of cars in the Milford Haven Energy Kingdom project. The company has also been featured in several prominent publications such as The Guardian, CNBC, BBC Wales, Reuters and CNN to name a few. The company will use the investment to expand its engineering team and start volume production to reach product commercialisation by the end of 2022.
days to go:
Expired
investment:
£504,000
